Viewing Decellularized Amniotic Membrane Through the Lens of Coupled Scaffolding and Drug Delivery Systems in Regenerative Medicine
Journal of Tissue Engineering and Regenerative Medicine · 2025-01 · 2025 (1)
DOI: 10.1155/term/8818058 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Tissue Engineering and Regenerative Medicine, online erschienen am 23.07.2025. Verfasst von Fatemeh Alibabaei-Omran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran. Hauptthemen laut MEDLINE: Amnion, Regenerative Medicine, Drug Delivery Systems, Tissue Scaffolds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Regenerative medicine (RM) exploits stem cells to construct biological replacements and repair damaged tissues, offering an alternative to daunting organ transplantation. Even while RM has advanced quickly, building an entire organ remains beyond our capabilities. Experts are thus investigating the adoption of biologically generated composites that preserve the tissue’s crucial physiological, morphological, and mechanical characteristics. Noncellular tissues like extracellular matrix offer cells a milieu similar to their physiological niche, becoming a promising substitute for synthetic composites. In this context, amnion, the membrane enclosing the fetus, is a great contender since it is widely obtainable and economical. Given its biochemical and anatomic characteristics, and the extensive supply of stem cells, growth factors, and matrix proteins, the amnion is considered a fantastic candidate to employ in RM. Decellularized amniotic membrane (DAM) has many uses as two‐ and three‐dimensional scaffolds, anchoring for cell adhesion and expansion for tissue regeneration, and as carrier systems for cell and drug cargoes. The present research aims to assess the recent surge in DAM‐RM research, potentially to get beyond the existing barriers impeding the RM’s clinical translation landscape. The present paper draws a comprehensive picture of the experimental evidence and clinical trials regarding exploiting DAM in RM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
- Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
- Department of Pharmacology & Toxicology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
- USERN Office, Babol University of Medical Sciences, Babol, Iran.
- Department of Clinical Biochemistry, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
- Laboratory and Pathology Services, UChicago Medicine Adventhealth, La Grange, Illinois, USA.
ORCID-Profile: Ebrahim Zabihi
Zitieren
APA
Alibabaei-Omran, F., Javanmehr, N., Al-E-Ahmad, A., Zabihi, E., & Najafi, T. (2025). Viewing Decellularized Amniotic Membrane Through the Lens of Coupled Scaffolding and Drug Delivery Systems in Regenerative Medicine. Journal of Tissue Engineering and Regenerative Medicine, 2025(1). https://doi.org/10.1155/term/8818058
Vancouver
Alibabaei-Omran F, Javanmehr N, Al-E-Ahmad A, Zabihi E, Najafi T. Viewing Decellularized Amniotic Membrane Through the Lens of Coupled Scaffolding and Drug Delivery Systems in Regenerative Medicine. Journal of Tissue Engineering and Regenerative Medicine. 2025;2025(1). doi:10.1155/term/8818058
BibTeX
@article{AlibabaeiOmran2025,
author = {Alibabaei-Omran, Fatemeh and Javanmehr, Nima and Al-E-Ahmad, Atiyeh and Zabihi, Ebrahim and Najafi, Tohid},
title = {Viewing Decellularized Amniotic Membrane Through the Lens of Coupled Scaffolding and Drug Delivery Systems in Regenerative Medicine},
journal = {Journal of Tissue Engineering and Regenerative Medicine},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/term/8818058}
}
EUVIMED